Status: current, Defined. Date: 31-Mar 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1561851000168111 | Oralair Continuation Treatment 300 IR (Anthoxanthum odoratum pollen extract 60 IR + Dactylis glomerata pollen extract 60 IR + Lolium perenne pollen extract 60 IR + Phleum pratense pollen extract 60 IR + Poa pratensis pollen extract 60 IR) sublingual tablet, 100 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1561861000168113 | Oralair Continuation Treatment 300 IR sublingual tablet, 100 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Oralair Continuation Treatment 300 IR sublingual tablet, 100 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Oralair Continuation Treatment 300 IR sublingual tablet, 100 | Is a | Dactylis glomerata pollen extract + Poa pratensis pollen extract + Lolium perenne pollen extract + Anthoxanthum odoratum pollen extract + Phleum pratense pollen extract (total 300 IR) sublingual tablet, 100 | true | Inferred relationship | Some | ||
| Oralair Continuation Treatment 300 IR sublingual tablet, 100 | has TPUU | Oralair Continuation Treatment 300 IR sublingual tablet | true | Inferred relationship | Some | 1 | |
| Oralair Continuation Treatment 300 IR sublingual tablet, 100 | has TP | Oralair Continuation Treatment 300 IR | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Oralair Continuation Treatment 300 IR sublingual tablet, 100, blister pack | Is a | True | Oralair Continuation Treatment 300 IR sublingual tablet, 100 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR